Yok Lam Kwong (Yok-Lam Kwong, Yok L Kwong)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 49

Top Topics

Newly Diagnosed

Hodgkin Lymphoma

Prognostic Factors

Diffuse Large B Cell Lymphoma

Top Venues

Annals of hematology

Bone marrow transplantation

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Carol Y M Cheung, Rock Y Y Leung, Anthony Raymond Tam, Joycelyn P Y Sim, Yok Lam Kwong
Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia. Annals of hematology (2023)
Carol Y M Cheung, Rock Y Y Leung, Anthony Raymond Tam, Joycelyn P Y Sim, Yok Lam Kwong
Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia. Annals of hematology 102 (2) (2023)
Carol Y M Cheung, Rock Y Y Leung, Anthony Raymond Tam, Joycelyn P Y Sim, Yok Lam Kwong
Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia. Annals of hematology 102 (2) (2023)
Carol Y M Cheung, Rock Y Y Leung, Anthony Raymond Tam, Joycelyn P Y Sim, Yok Lam Kwong
Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia. Annals of hematology 102 (2) (2023)
Eric Wai-Choi Tse, Yok Lam Kwong, Yeow Tee Goh, Ping Chong Bee, Soo Chin Ng, Daryl Tan, Priscilla Caguioa, Huynh Nghia, Teresita Dumagay, Lalita Norasetthada, Suporn Chuncharunee, Radhakrishnan Vs, Bhausaheb Pandurang Bagal, Tubagus Djumhana Atmakusuma, Nadia Ayu Mulansari
Expert consensus on the management of chronic lymphocytic leukaemia in Asia. Clinical and experimental medicine (2023)
Yu-Yan Hwang, Thomas S Y Chan, Florence H Y Chan, Chris W P Lau, Yan-Yan Luk, Grace W N Lau, Ka-Po Chan, Kwan-Hung Leung, Bonnie Kho, June S M Lau, Chi-Kuen Lau, Vivien Mak, Sze-Fai Yip, Shek-Ying Lin, Joycelyn P Y Sim, Yok Lam Kwong
Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy. Annals of hematology 101 (6) (2022)
Bryan A Bassig, Wei Hu, Lindsay M Morton, Bu-Tian Ji, Jun Xu, Martha S Linet, Yok Lam Kwong, Nathaniel Rothman, Kit-Fai Wong, Qing Lan
Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States. Leukemia & lymphoma 63 (8) (2022)
Ryan C W Ho, Chun-To Poon, Birgitta Y H Wong, Joseph C K Chung, Edward Y L Chu, Yok Lam Kwong
Bilateral deafness in NK/T-cell lymphoma: EBV DNA prevailed over magnetic resonance imaging. Annals of hematology 101 (8) (2022)
Burhan Ferhanoğlu, Tae Min Kim, Amado J Karduss-Urueta, David Brittain, Gayane Tumyan, Mubarak Al-Mansour, Marta Zerga, Yuqin Song, Silvia Rivas-Vera, Yok Lam Kwong, Soon Thye Lim, Su-Peng Yeh, Arif Abdillah, Zhongwen Huang, Mehul Dalal, Hui Wan, Mark Hertzberg
Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study. Leukemia & lymphoma (2022)
Harinder Gill, Rex Au-Yeung, Florence Loong, Yok Lam Kwong
CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma. Annals of hematology (2021)
Yu-Yan Hwang, Rock Y Y Leung, Gavin S W Chan, Cyril C Y Yip, Yok Lam Kwong
Thrombotic thrombocytopenic purpura as the presenting feature of human herpesvirus 6 myocarditis. Annals of hematology 100 (11) (2021)
Ryan C W Ho, Thomas S Y Chan, Rex Au-Yeung, Karen H K Tang, Yu-Yan Hwang, Eric Tse, Yok Lam Kwong
Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease. Annals of hematology (2021)
Garret M K Leung, Joycelyn P Y Sim, Yu-Yan Hwang, Thomas S Y Chan, Albert K W Lie, Eric Tse, Yok Lam Kwong
Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre. Annals of hematology (2021)
Eric Tse, Rex Au-Yeung, David Chau, Yu-Yan Hwang, Florence Loong, Yok Lam Kwong
Epstein-Barr virus-positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma. Annals of hematology (2021)
Chor-Sang Chim, Shaji K Kumar, Vincent Kai Chung Wong, Michael Cheong Ngai, Yok Lam Kwong
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma. Hematology (Amsterdam, Netherlands) 26 (1) (2021)
Karen H K Tang, Alvin H W Ip, Yok Lam Kwong
Clonal derivation of sequential seminoma and acute megakaryoblastic leukaemia. Annals of hematology 100 (5) (2021)
Harinder S Gill, Rita Yim, Cyrus R Kumana, Eric Tse, Yok Lam Kwong
Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators. Cancer 126 (14) (2020)
Ian Y Wong, Wing-Lau Ho, Lawrence P Iu, Ken H P Lau, Pak-Leung Ho, Yok Lam Kwong
EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis. Annals of hematology 100 (12) (2020)
Harinder Gill, Rita Yim, Herbert H Pang, Paul Lee, Thomas S Y Chan, Yu-Yan Hwang, Garret M K Leung, Ho-Wan Ip, Rock Y Y Leung, Sze-Fai Yip, Bonnie Kho, Harold K K Lee, Vivien Mak, Chi-Chung Chan, June S M Lau, Chi-Kuen Lau, Shek-Yin Lin, Raymond S M Wong, Wa Li, Edmond S K Ma, Jun Li, Gianni Panagiotou, Joycelyn P Y Sim, Albert K W Lie, Yok Lam Kwong
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation. Cancer medicine 9 (10) (2020)
Thomas S Y Chan, Yu-Yan Hwang, Pek-Lan Khong, Anskar Y H Leung, Chor-Sang Chim, Eric W C Tse, Yok Lam Kwong
Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource-constrained setting. Hematological oncology 38 (5) (2020)
Karen H K Tang, Rex Au-Yeung, Shun-Hin Ting, Yok Lam Kwong
CD30 expression: a diagnostic pitfall for primary cutaneous gamma delta T cell lymphoma. Annals of hematology 100 (10) (2020)
Sze P Tsui, Ho W Ip, Nicole Y Saw, Chunxiao Zhang, Arthur K Cheung, Nelson K Ng, Cheuk H Man, Stephen S Y Lam, Wing F Tang, Chi H Lin, Grace H Cheng, Chun H Au, Edmond S Ma, Tsun L Chan, Jason C So, Margaret H Ng, Kelvin C Cheng, Kit F Wong, Lai P Siu, Sze F Yip, Shek Y Lin, June S Lau, Tsan H Luk, Harold K Lee, Chi K Lau, Bonnie Kho, Joycelyn P Sim, Yok Lam Kwong, Suet Y Leung, Asif Javed, Anskar Yu-Hung Leung
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults. Blood cancer journal 10 (10) (2020)
Rex Au-Yeung, Florence Loong, Yok Lam Kwong
CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma. Annals of hematology 100 (4) (2020)
Thomas S Y Chan, Alvin H W Ip, Rex Au-Yeung, Annie W K Pang, Yok Lam Kwong
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus-positive plasma cell myeloma. Annals of hematology 99 (12) (2020)
Chunxiao Zhang, Stephen S Y Lam, Garret M K Leung, Sze-Pui Tsui, Ning Yang, Nelson K L Ng, Ho-Wan Ip, Chun-Hang Au, Tsun-Leung Chan, Edmond S K Ma, Sze-Fai Yip, Harold K K Lee, June S M Lau, Tsan-Hei Luk, Wa Li, Yok Lam Kwong, Anskar Yu-Hung Leung
Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3. Cancer 126 (2) (2019)
Harinder Gill, Cyrus R Kumana, Rita Yim, Yu-Yan Hwang, Thomas S Y Chan, Sze-Fai Yip, Harold K K Lee, Vivien Mak, June S M Lau, Chi-Chung Chan, Bonnie Kho, Raymond S M Wong, Wa Li, Shek-Yin Lin, Chi-Kuen Lau, Ho-Wan Ip, Rock Y Y Leung, Clarence C K Lam, Yok Lam Kwong
Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study. Cancer 125 (17) (2019)
Yok Lam Kwong, Florence Loong, Pek-Lan Khong
Low-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab. Annals of hematology 98 (10) (2019)
Joycelyn P Y Sim, Rex Au-Yeung, Yok Lam Kwong
Low-dose pembrolizumab induced complete radiologic and molecular response of posttransplant lymphoproliferative disorder presenting as classical Hodgkin lymphoma. Annals of hematology 99 (2) (2019)
Annie Pang, Rex Au-Yeung, Rock Y Y Leung, Yok Lam Kwong
Addictive response of primary cutaneous diffuse large B cell lymphoma leg type to low-dose ibrutinib. Annals of hematology 98 (10) (2019)
Thomas S Y Chan, Pek-Lan Khong, Rex Au-Yeung, Yok Lam Kwong, Eric Tse
Low-dose nivolumab induced durable complete response in relapsed primary central nervous system diffuse large B cell lymphoma. Annals of hematology 98 (9) (2019)
Harinder Gill, Garret M K Leung, Wai-Kay Seto, Yok Lam Kwong
Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment. Annals of hematology 98 (1) (2018)
Harinder Gill, Ho-Wan Ip, Rita Yim, Wing-Fai Tang, Herbert H Pang, Paul Lee, Garret M K Leung, Jamilla Li, Karen Tang, Jason C C So, Rock Y Y Leung, Jun Li, Gianni Panagioutou, Clarence C K Lam, Yok Lam Kwong
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis. Annals of hematology 98 (4) (2018)
Harinder Gill, Rita Yim, Harold K K Lee, Vivien Mak, Shek-Ying Lin, Bonnie Kho, Sze-Fai Yip, June S M Lau, Wah Li, Ho-Wan Ip, Yu-Yan Hwang, Thomas S Y Chan, Eric Tse, Wing-Yan Au, Cyrus R Kumana, Yok Lam Kwong
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study. Cancer 124 (11) (2018)
Yu-Yan Hwang, Pek-Lan Khong, Yok Lam Kwong
Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma. Annals of hematology 96 (7) (2017)
Yok Lam Kwong, Thomas S Y Chan, Daryl Tan, Seok Jin Kim, Li-Mei Poon, Benjamin Mow, Pek-Lan Khong, Florence Loong, Rex Au-Yeung, Jabed Iqbal, Colin Phipps, Eric Tse
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase. Blood 129 (17) (2017)
Joyce H Y Kwong, Rock Y Y Leung, Michael L G Wong, Harinder Gill, Yok Lam Kwong
Primary myelofibrosis presenting in acute promyelocytic transformation. British journal of haematology 178 (3) (2017)
Yu-Yan Hwang, Rex Au-Yeung, Hon-Pang Lau, Yok Lam Kwong
Complete response of age-related Epstein-Barr virus-associated polymorphic nodal lymphoproliferative disease of plasmacytic type to low-dose lenalidomide. Annals of hematology 97 (2) (2017)
Bonnie Kho, Howard H N Wong, Chun-Fung Sin, Rock Y Y Leung, Yok Lam Kwong
Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab. Annals of hematology 96 (12) (2017)
Thomas S Y Chan, Joycelyn P Y Sim, Yok Lam Kwong
Low-dose nivolumab-induced responses in acute lymphoblastic leukaemia relapse after allogeneic haematopoietic stem cell transplantation. Annals of hematology 96 (9) (2017)
Thomas S Y Chan, Yok Lam Kwong
Systemic trichosporonosis mimicking disseminated varicella zoster viral infection during blinatumomab therapy. Annals of hematology 97 (2) (2017)
Eric Tse, Yok Lam Kwong
The diagnosis and management of NK/T-cell lymphomas. Journal of hematology & oncology 10 (1) (2017)
Jamilla Li, Joycelyn Sim, Anskar Y H Leung, Yok Lam Kwong
Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin. Annals of hematology 97 (3) (2017)
Thomas S Y Chan, Jamilla Li, Florence Loong, Pek-Lan Khong, Eric Tse, Yok Lam Kwong
PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing L-asparaginase: efficacy and safety. Annals of hematology 97 (1) (2017)
Thomas S Y Chan, Vivien Mak, Yok Lam Kwong
Complete radiologic and molecular response of HIV-negative primary effusion lymphoma with short-course lenalidomide. Annals of hematology 96 (7) (2017)